Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
With regard to NK, look in the broader media to find your answer. NK is famous, but not admired. She's successful, but not for greatness. Consumers are not going to rush to buy anything she claims she loves or uses. Mostly because they assume, probably rightly so, that she uses other interventions. In showbiz, who doesn't have a plastic surgeon or dermatologist on call? Plus she does not CONNECT with the public at all.
OK, Profit Scout, if you are going to keep the pom poms going, then I have to ask. Can you tell me from where comes this "staggering 3 billion in revenue"? What "cutting edge marketing"? I'm curious now. Maybe I'm wrong, but in harder terms all I see are items of litigation, bankruptcy, FDA slaps, loads of customer consumer complaints, a failed novelty item with losses to investors, and a somewhat short term employment or association with a large marketing firm. Is this the source of the 3 billion you refer to? Because that would not be hers alone to claim....so what am I missing here? Continued high pay and benefits despite a failing company seem to be the theme here. Please enlighten. The internet is full of misinformation.
Nancy Duitch serves as the CEO of Avenir Wellness Solutions. With over three decades of experience in the consumer products sector, Nancy has cultivated a diverse array of businesses, guiding them from inception to the public market. Her expertise extends to orchestrating cutting-edge marketing and branding initiatives, resulting in a staggering $3 billion in revenue for esteemed brands. From her early years, Nancy exhibited a clear vision and pursued it with determination.
$AVRW Host April Franzino is joined by Nancy Duitch, CEO of
@SeralabsHealth
Nancy discusses how she has spent her entire career working on solution-based health, wellness and beauty products to help people look and feel their absolute best.
https://podcasts.apple.com/us/podcast/beauty-is-your-business-beautytech-and-beauty-innovation/id1211773564 #podcasts
Avenir Wellness Solutions, Inc. teetering on BANKRUPTCY
Buyer's or gambler's - be very careful with this one.
Read several pages of posts here before you pull the trigger.
Very low volume for a reason - a penny stock with no volume?
Huge amount of outstanding shares.
Just signed on to more TOXIC CONVERTIBLE DEBT.
EXHAUSTED CEO's own personal credit cards before taking on the latest TOXIC DEBT.
Doesn't get too much closer to BANKRUPTCY than that.
JUST SAYIN......
$AVRW Avenir Wellness Solutions, Inc. is a broad platform technology company that develops proprietary wellness, nutraceutical and topical delivery systems and currently holds fifteen patents. The technology offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path creating new innovative technologies as part of its incubator strategy in order to monetize its intellectual property. The Sera Labs, Inc. (“Sera Labs”), a wholly owned subsidiary of Avenir, is a trusted leader in the wellness and beauty sectors utilizing cutting edge technology and high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical™, Seratopical Revolution™ SeraLabs™, and Nutri-Strips™. The Company sells its products at affordable prices, making them easily accessible on a global scale and is strategically positioned to grow their beauty and wellness products into household brands. Sera Labs products are sold Direct to Consumer (DTC) via online website orders, including a subscribe and save option, as well as in major national drug, grocery chains, and mass retailers. For more information visit: Seralabshealth.com and follow Sera Labs on Facebook and Instagram at @seratopical, as well as on X (Twitter) at @sera_labs.
I wonder if Avenir paid the POM-POMS from the proceeds of their latest TOXIC FINANCING?
They work very hard and should get paid!!
$AVRW Seratopical DNA Complex reviews are in ...
https://www.youtube.com/shorts/sin3tdGRpQs
https://www.youtube.com/shorts/EzMBqOQZ6m4
I didn't blame it on her - just posted a fact.
Just was replying to the Nicole Kidman propaganda - and the fact that she has
been ambassador for a LONG time and it has done NOTHING for the pps.
As far as your friends, my friend also had close to 90K tied up in this POS
and he DIED while waiting on all of the smoke that got blown up his ass to
come to fruition - but of course it never did. I go back over 7 years posting
here - I know quite a bit about all of the lies and promises. Anyhow, have a
nice evening - sorry to hear your friends got screwed as well.
BTW - If you go back and read my posts for the last 3 years - I've been warning
other's and supplied good info to back up my warnings - some people just don't
learn.
CURR / SERA LABS / AVENIR = FAILURE
Blaming a celebrity endorsement on this failure is laughable. My friends had 100k$ CURR Certs and really believed the Kool Aid back in the beginning.
The true story is WAY longer than the endorsement.
POM-POMS are continuously posting old BS to try and pump up these dreadful shares.
Nothing will help!!
With all the Money that Nicole Kidman is making from the astronomical sales of Sera Topicals, I'm just wondering when she actually walks away from this Company and takes her pretty face elsewhere?
BEFORE NICOLE KIDMAN $1.83 AFTER NICOLE KIDMAN .03
The AVRW Seratopical Revolution skin care brand is the #1 Choice for top film and television actress Nicole Kidman.
Nicole Kidman Skincare | Nicole Kidman's Beauty Secrets
Can't wait to see the sales numbers for Q2 when the 10Q comes out in 3 weeks. I'm sure it must be VERY frustrating to Nancy not to have the funding to advertise.
No $$$ = NO ADVERTISING = NO SALES!!!!
DEFAULTED DEBT AND NOW EVEN MORE DEBT THAT HAS DEATH SPIRAL CONVERSION FEATURES!!
$AVRW #OTCQB Great Products. Introducing Seratopical Gleaming Brightener with Licorice Root Extract
THE ONLY "MIRACLE" - THEY ARE STILL OPEN
$AVRW: "Women from cost-to-coast have discovered a new life-changing anti-aging miracle called DNA Complex"
AVRW HAS HIGH INTEREST TOXIC DEBT, BANKRUPTCY LOOMS
Without a miracle.
And the following doesn't even include the latest form (8K) TOXIC LOAN SHARK DEBT
they just had to sign.... to keep the business open after exhausting the CEO's credit
cards.
BUYER BEWARE !
https://simplywall.st/stocks/us/pharmaceuticals-biotech/otc-avrw/avenir-wellness-solutions/health
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001643301/000147793224000136/avrw_8k.htm
https://www.sec.gov/ix?doc=/Archives/edgar/data/1643301/000147793224004082/avrw_8k.htm
$AVRW Solid Growth Reported for Seratopical Revolutions Skin Care Line with Boost from Famed Beauty Box FabFitFun and Endorsements from Key Celebrities, Influencers and Top Medical Professionals: Avenir Wellness Solutions, Inc. (Stock Symbol: AVRW) https://www.einpresswire.com/article/711238053/solid-growth-for-seratopical-revolutions-skin-care-line-boost-from-famed-fabfitfun-many-key-celebrities-otc-avrw
Celebrity endorsements always fail in shams
Whomever the "auditor" is, they shouldn't get paid much.
Talk about a messy filing "as usual though". In one paragraph they say
they had to pay out higher wages to "an increase in employee's" and in
the subsequent paragraph when they are speaking of savings.. they
attributed part of that to "less employee's during the period"
Talk about a blatant error - I mean shit - they were right next to each other
in the filing. I posted it exactly in a previous post here.
Generally, when an extension is filed like that - they have to find area's where
they can make "adjustment's" to hide shit. Well, they hide shit - but if you look
you can see all of the mistakes and the FACT that they continue to BLEED in
DEBT and aren't making enough revenue to pay it down.
BANKRUPTCY remains my call without some MIRACLE coming into play.
It is obvious that this additional debt closed on June 28th so that Avenir would be able to show a small amount of cash on the end of 2nd quarter 10Q. Sad situation!! We'll get to see the 10Q by August 15th.
I'd also bet the funds were needed to pay the auditor to do the 10Q.
A big $6 trade brings it back even on the day.
This trades so thinly (not too many gambler's) that $6 one way or the other
can take it from .033 to .045
One would think you could make money on that type of spread - but not with the
minuscule volume traded on this penny stock.
BANKRUPTCY LOOMS - RESORTED TO LOAN SHARK BRIDGE LOAN AFTER
RUNNING OUT OF BUCKS ON CEO'S PERSONAL CREDIT CARDS - WOW
$AVRW Avenir Wellness Solutions Inc (QB) (AVRW) Quote: https://ih.advfn.com/stock-market/USOTC/avenir-wellness-solutions-qb-AVRW/stock-price
With only $28.00 traded, they have to.
Facts and Numbers - Numbers and Facts
BANKRUPTCY or MIRACLE
The POM-POM GROUP working overtime!! Sign of desperation!
Getting good vibes from AVRW!
Are the POM-POMS willing to use their own funds to buy "cheap" shares?? \
The answer is and has been a resounding NO!! They are only here to try and mislead YOU to go buy shares. Obviously, it hasn't worked, No one is foolish enough to buy these shares!!
NO $$$$!!!! FLAT SALES!! DEFAULTED DEBT!!! RD is still Chairman after taking the CROWN JEWEL patents to his own private Company.
Agreed Dickmo. Solid Growth Reported for Seratopical Revolutions Skin Care Line with Boost from Famed Beauty Box FabFitFun and Endorsements from Key Celebrities, Influencers and Top Medical Professionals: Avenir Wellness Solutions, Inc. (Stock Symbol: AVRW) https://www.einpresswire.com/article/711238053/solid-growth-for-seratopical-revolutions-skin-care-line-boost-from-famed-fabfitfun-many-key-celebrities-otc-avrw $AVRW
Looking forward to seeing continued revenue increases in future quarters.
Numbers and Facts, not company propaganda.
They couldn't pull through with the funds from the CEO's credit cards so
they had to go to a LOAN SHARK outfit to keep the lights on. I don't care
how much they "twist words" to show they are losing a little bit less money,
they are so far in the hole there is no way out without a MIRACLE.
They have sooooo much debt and continue to pile it on. Case closed.
BANKRUPTCY LOOMS
We expect accelerating sales will reaffirm the improving overall trajectory of the business. Further, our margin expansion initiatives continue to deliver results with improvement from third quarter, and we continue our overall cost containment initiatives to further reduce SG&A expenses and to maximize operating leverage.
Fine tuning our Search Engine Optimization (SEO), bringing our media buying in house and achieving successful monthly campaigns like theSkimm continue to deliver for us as we execute on our strategy to build our brands," said Nancy Duitch, Avenir CEO.
Friday, 17 May 2024
Source:
https://www.accesswire.com/864776/avenir-wellness-solutions-reports-fourth-quarter-2023-results
Kicking the can down the road.
The last (2) 8K's should alert investor's to the absolute possibility of bankruptcy.
An 8K that details that the company was taking high interest loans from the CEO's
own personal credit cards is a BIG RED FLAG.
The recent 8K detailing that they then had to go to 1800 Diagonal at LOAN SHARK
interest rates and CONVERTIBLE NOTES is another VERY LARGE RED FLAG.
Again, how anyone can be BULLISH the current situation is beyond my capacity of
understanding. The FACTS & NUMBERS have been provided on multiple ocassions
by both of us who have been following this company for a VERY LONG TIME.
Oh well - sometimes people just love to gamble.
POM-POMS keep repeating the same old BS while totally ignoring the real fundamentals .
This Company barely has a pulse and POM-POMS keep pumping. VERY SAD!!
PURA VIDA!!
$AVRW CEO Interview with Nancy Duitch of Avenir Wellness Solutions. Nancy has over three decades of experience in the consumer products sector and has cultivated a diverse array of businesses, guiding them from inception to the public market
$AVRW: Nicole Kidman chats with CEO Nancy Duitch
$AVRW Seratopical Gleaming Brightener with Licorice Root Extract
NUMBERS AND FACTS NOT COMPANY PROPAGANDA
READ THE 10K COMPLETELY, DEBT, LITIGATION, RUNNING DEFICIT.
READ THE 8K ABOUT LOAN FROM CEO WHICH WAS ON HER HIGH INTEREST CREDIT CARDS.
READ THE LATEST 8K WITH CONVERTIBLE NOTES/SHARE DEBT FROM LATEST LOAN SHARK.
THIS COMPANY HAS HUGE DEBT WITH A 79MM VERY BLOATED SHARE COUNT.
HARD TO INCREASE PPS WITH THIS DEBT AND SHARE STRUCTURE.
BANKRUPTCY OR MIRACLE - GO AHEAD AND BUY IF YOU ARE A HUGE GAMBLER.
"Avenir Wellness Solutions has never been in a better position to capitalize on the high intrinsic value of our unique and proprietary skin care formulations. With 15 patents under our control, the highly positive reviews Seratopical DNA Complex is receiving, and more new products in development, 2024 is set up to be a growth year for the Company. We look forward to keeping our shareholders informed of our progress, developments and milestones as we move forward.
Sincerely,
Nancy Duitch, CEO"
Source:
https://finance.yahoo.com/news/avenir-wellness-solutions-issues-2024-140000098.html
$AVRW Avenir Wellness Solutions is a broad platform technology company developing unique ingredients and cutting-edge delivery systems. Celebrity spokesperson #NicoleKidman for
@avenirwellness @Sera_Labs
https://avenirwellness.com/investors
#OTCQB (AVRW) Products Sold on AMAZON Stores and Available at Walmart and other retailers.
One word for this: UGLY!!!
STUCK BETWEEN A ROCK AND A HARD SPOT
Yes, Hefty interest rates, hefty 30% automatic pps shave etc. etc. etc.
That is why I spoke of HEFTY and DESPERATION. IONIC's terms were similar.
Not sure why this company is even doing this really. Maybe they believe Avenir is
behind the 8-ball and they will HAVE to pay through the nose - no matter what.
Not sure how 1800 would even be able to sell into the market - there's really no volume
but I suppose they will create PANIC and the price will drop below ONE CENT Quickly.
Hell, depending on conversion price - they could take the outstanding to the full 150,000,000
shares allotted in order to recoup their money. If there is default and conversion, the price will
drop quite quickly. It might start to drop quickly just due to the fact of so much more debt.
These are definitely LOAN SHARK rates - or even very poor credit - CREDIT CARD
rates. Definitely much more debt to tack on to the deficit - that is, if they survive.
BANKRUPTCY LOOMS.
If repayment is defaulted, then note converts to shares as stated below....
4.2 Conversion Price. The Conversion Price shall equal the Variable Conversion Price (subject to equitable adjustments for stock splits, stock dividends, or rights offerings by the Borrower relating to the Borrower’s securities or the securities of any subsidiary of the Borrower, combinations, recapitalization, reclassifications, extraordinary distributions, and similar events). “Variable Conversion Price” means seventy percent (70%) multiplied by the Market Price (as defined herein) (representing a discount rate of thirty percent (30%)). “Market Price” means the lowest Trading Price (as defined below) for the Common Stock during the ten (10) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. “Trading Price” means, for any security as of any date, the closing bid price on the or applicable exchange or trading market (the “Trading Market”) as reported by a reliable reporting service designated by the Holder (i.e., Bloomberg) or, if the Trading Market is not the principal trading market for such security, the closing bid price of such security on the principal securities exchange or trading market where such security is listed or traded or, if no closing bid price of such security is available in any of the foregoing manners, the average of the closing bid prices of any market makers for such security that are listed in the “pink sheets.” If the Trading Price cannot be calculated for such security on such date in the manner provided above, the Trading Price shall be the fair market value as mutually determined by the Borrower and the holders of a majority in interest of the Notes being converted for which the calculation of the Trading Price is required in order to determine the Conversion Price of such Notes. “Trading Day” shall mean any day on which the Common Stock is tradable for any period on the Trading Market, or on the principal securities exchange or other securities market on which the Common Stock is then being traded.
"IF" 1800 Diagonal Converted, it would add 10% or over 8 Million More shares
at current pricing. Total loan amount of 350,000 dollars divided by .0418 and that
would take the share count to approximately 88 Million outstanding.
Would definitely be just like IONIC if they began converting due to default and selling
shares like crazy - but - there would have to be PANIC for them to even sell as the
volume is so low.
I can't really believe they even did the deal. (1800 Diagonal that is)
8K - My prior post that I am now replying to, well.... it isn't as important anymore.
It appears that the credit on Nancy Duitch's personal credit card must have run
it's course and now the company has had to go to LOAN SHARKS similar to what
CURE did with IONIC. NANCY HAD TO SELL HER SOUL TO THE DEVIL.
The terms are pretty HEFTY and now if there is a DEFAULT - NANCY is screwed just
as much as the rest of the Corporation - because NOW - even Nancy can't call her loan
until 1800 Diagonal get's their money or converted NOTES first.
https://fintel.io/doc/sec-avenir-wellness-solutions-inc-1643301-8k-2024-july-05-19909-5634
In case you don't have access to FINTEL - here is the SEC link:
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001643301/000147793224004082/avrw_8k.htm
Oh what a crazy assed web of money here, money there - money that is just DEBT DEBT
DEBT and MORE DEBT.
WOWSA.
INTERESTING - JUST FOUND THIS - MORE DEBT
But, maybe they can pull a rabbit out of the hat.
https://fintel.io/doc/sec-avenir-wellness-solutions-inc-1643301-8k-2024-july-05-19909-5634
Wow though - the terms look quite a bit like the IONIC agreement with the notes being convertible
and not much wiggle room - smells of desperation. Who knows.... but the line of credit on ND's
cards must have run out.
Note A shall be payable in four installments and Note B shall be payable in ten installments as set forth specifically within each Note. Pursuant to the Notes, after the occurrence of an Event of Default, the outstanding and unpaid portion of each Note is convertible into the Company’s Class A common stock, par value $0.001 par value per share (“Common Stock”) at a conversion price (“Conversion Price”) calculated by multiplying 70% of the lowest Trading Price for the Common Stock during the ten-day Trading Period ending on the latest complete trading day prior to the Conversion Date. The Conversion Price is subject to equitable adjustments for stock splits, stock dividends, or rights offerings by the Company relating to the Company’s securities or the securities of any subsidiary of the Company, combinations, recapitalization, reclassifications, extraordinary distributions, and similar events. The number of shares of Common Stock to be issued upon each conversion of the Note is determined by dividing the outstanding amount owed on the Note by the Conversion Price.
Each Note shall have a one-time interest charge of 15% on Note A and 14% on Note B applied on the issuance date to the respective principal amount of each Note. Any amount of principal or interest on each Note which is not paid when due shall bear an interest rate of 22% per annum from the due date thereof until such principal or interest is paid. The Company has the right to repay each Note in full at any time with no prepayment penalty.
IN THE EVENT OF BANKRUPTCY - WHO WOULD COME OUT OKAY?
As can be seen by the terms of the "LOAN" agreement between the Corporation
and Nancy Duitch, Nancy Duitch now holds security and interests in the company
as a "PRIVATE" individual. In my eyes, Nancy Duitch will end up owning SeraLabs
once again as a PRIVATE company - and - those poor souls still wishing and hoping
for the miracle - the current stockholder's - well under corporate bankruptcy in a publicly
traded company - they will get SQUAT - nada - nill - I'd take the 4 cents or better bid if
I was still holding any shares in this "SHADY" non-transparent company.
SEE THIS FROM A SECTION OF THE 8k I just previously posted
The Company granted the Executive a security interest in all of the Company’s present and future personal property.
(iv) the Company is the subject of an involuntary bankruptcy petition and such petition is not dismissed within sixty (60) days.
Yes, Nancy Duitch may have some decent credentials for running "private" startups
and "marketing" new products - but - has she ever run a publicly traded company before ?
The answer there is "NO".
And, Nancy has always started with a clean slate. Has she ever been burdened with a
10.5 Million DOLLAR annual deficit ? Has she ever been burdened by (by my estimations) an over 18 Million Dollar defaulted loan (including interest and penalties)? Has she ever had to operate with a mushroom cloud of 78 Million outstanding share count and the inability to even use a publicly traded company to raise funds (due to defaulted debt and not able to issue more shares due to the defaulted debt) ?
I personally believe all of the WEIGHT she has inherited due to her partnership with Rob Davidson's Cure Pharmaceuticals, subsequent loan default, TF Tech Ventures attempted bail out by buying back rights to the Oxnard manufacturing facilities and staff along with key patents - and the fact that her buddy Rob Davidson didn't pay all the monies owed - has indeed - put Nancy into quite the bind.
When a publicly traded company has to operate off of a "LOAN" from the CEO's own personal credit cards "which may be exhausted at this moment in time" (8k info listed below) it is truly hard to be "bullish" in the matter of Nancy's ability to drag this company out of the money pit they are in. Truly an uphill battle which to me points to BANKRUPTCY without a MIRACLE on a WHITE HORSE coming to the rescue.
Time will tell.
8K Filing
Item 1.01. Entry into a Material Definitive Agreement.
On January 4, 2024, Avenir Wellness Solutions, Inc. (the “Company”) and Nancy Duitch, the Chief Executive Officer of the Company (the “Executive”), entered into that certain Senior Secured Promissory Note and Security Agreement (the “Agreement”).
The Agreement provides for a secured loan facility of up to $250,000, of which the Company borrowed an initial amount of $39,000 (the “Initial Principal Amount”) on January 4, 2024. The Agreement provides for the ability of the Company to request additional loan amounts up to $211,000 (the “Future Advances”), inclusive of the outstanding balances of certain credit cards (the “Cards”) used exclusively by the Company of which are issued in the name of the Executive. The portion of the principal amount of the Agreement (the “Principal Amount”) comprised of the Initial Principal Amount and the Future Advances (and excluding the outstanding balances on the Cards), accrues interest at an annual rate of 12%, or 18% in the event of default. The Principal Amount plus all accrued and unpaid interest is due and payable in full on the sooner of: (i) the demand of the Holder; and (ii) March 31, 2024. The Company may prepay the Principal Amount, in whole or in part, without the prior written consent of the Executive and without penalty. The Company granted the Executive a security interest in all of the Company’s present and future personal property.
In the event of default, the Executive may, upon written notice to the Company, declare the Principal Amount, including any accrued interest, immediately due and payable in cash and in full. The following constitutes events of default: (i) the Company fails to pay when due any principal or interest payment on the due date, and such payment has not been made within ten (10) days of the Company’s receipt of the Executive’s written notice to the Company of such failure to pay; (ii) the Company materially breaches any other covenant contained in the Agreement and such failure continues for fifteen (15) days after the Company receives written notice of such material breach from the Executive; (iii) the Company voluntarily files for bankruptcy protection or makes a general assignment for the benefit of creditors; or (iv) the Company is the subject of an involuntary bankruptcy petition and such petition is not dismissed within sixty (60) days.
The Agreement contains customary representations and warranties and customary affirmative covenants applicable to the Company. The foregoing description of the Agreement is not intended to be complete and is qualified in its entirety by reference to the full text of the Agreement, a copy of which is filed as Exhibit 10.1 hereto and is incorporated by reference herein.
Yes, this new interview with AVRW CEO Nancy Duitch clearly illustrates her strengths and experience in developing an emerging business. With Nancy's leadership and the proven value in the Avenir Wellness product line, AVRW should have prosperous future ahead.
------------------------------------------------------------------------------------------------------------
Nancy Duitch serves as the CEO of Avenir Wellness Solutions. With over three decades of experience in the consumer products sector, Nancy has cultivated a diverse array of businesses, guiding them from inception to the public market. Her expertise extends to orchestrating cutting-edge marketing and branding initiatives, resulting in a staggering $3 billion in revenue for esteemed brands. From her early years, Nancy exhibited a clear vision and pursued it with determination.
Followers
|
35
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3790
|
Created
|
11/14/16
|
Type
|
Free
|
Moderators ProfitScout Dickmo jedijazz greendolphin11 Student of the Game BlazingStocks |
Avenir Wellness Solutions (OTC: AVRW)
Formerly CURE Pharmaceutical (OTC: CURR)
For more information, please visit: www.avenirwellness.com and www.seralabshealth.com
COMPANY UPDATE:
Press Release | 02/13/2024
Link: https://feeds.issuerdirect.com/news-release.html?newsid=6554360501139897
Brand New Avenir Wellness DNA Product: https://seralabshealth.com/products/dna-complex
CEO INTERVIEW on Apple Podcasts:
"Lifetime of Health and Wellness - Nancy Duitch, CEO The Sera Labs"
Host April Franzino is joined by:
Nancy Duitch, CEO of The Sera Labs (see image below).
"Nancy discusses how she has spent her entire career working on solution-based health, wellness and beauty products to help people look and feel their absolute best."
Instagram: https://www.instagram.com/beautybizshow/
See omnystudio.com/listener for privacy information.
AVENIR WELLNESS: BUILDING INOVATIVE WELLNESS TECHNOLOGIES FOR THE FUTURE
Avenir Wellness is a vertically integrated drug delivery and development company
Committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage
Spokesperson Nicole Kidman, Actor (see image below).
Visit the Seratopical Store on AMAZON
LINK: https://www.amazon.com/stores/SERATOPICAL/page/473637CB-F4D4-470C-B60D-7B3885CDED6E?ref_=ast_bln
The plant based, alcohol-free, non-CBD, anti-aging beauty line is available Wednesday, June 9
Sera Labs, a subsidiary of Avenir Wellness Solutions, announced a new ad campaign and launch of Seratopical Revolution, a new clean, plant-based, technologically advanced, anti-aging, ‘revolutionary,’ beauty line.
Nicole Kidman and Sera Labs Inc., an Avenir Wellness Solutions Company, launch Seratopical Revolution. (Photo: Business Wire)
The line touts 11 luxurious products which are all are made in the U.S., available at accessible pricing, and are designed to make you feel more youthful and hydrated from head to toe. Award-winning actress Nicole Kidman, Sera Labs’ strategic business partner and global brand ambassador, collaborated with Sera Labs to design the Loving Hands Essential Oil , Indulgence Brown Sugar Scrub , Harmony Face & Neck Toner , and Gleaming for the ultimate brightening glow. The full line of products can be seen at Seratopicalrevolution.com .
“I really wanted to create something that was meaningful to me and that I knew people would genuinely enjoy,” said Kidman, Seratopical strategic business partner and global brand ambassador. “These products are personal to me from the scent to the texture. I am so excited to share them with the world and hope everyone loves them as much as we do.”
Seratopical Revolution marries nature and science into one clean and nourishing line of beauty products. The line’s P?P complex, developed by CURE Pharmaceutical, drives natural, plant-based ingredients into the deeper layers of the skin by utilizing a proprietary tri-peptide delivery system. Unlike other companies that use alcohol as a delivery system, which is incredibly drying to the skin, Seratopical Revolution’s natural oil and surfactant delivery systems are efficacious and offer almost immediate results.
“It’s been an incredible ride creating this line with Nicole,” said Nancy Duitch , Sera Labs CEO and CURE Pharmaceutical Chief Strategic Officer. “There are a lot of beauty companies, but the problem is that most of them don’t understand that without an effective delivery system, the products are sitting on top of your skin and clogging your pores. Our proprietary formulators have developed a high-tech delivery system which allows the ingredients to go deep into the skin. Our loyal customers will benefit from scientifically backed ingredients that are designed to enhance hydration and rejuvenate collagen. Revolution offers a full-body line packed with natural plant extracts and peptide blends.”
Seratopical Revolution products can be purchased online at seratopicalrevolution.com
Ad campaign photo and product images: https://www.dropbox.com/sh/o8l39o5xb0yj4bs/AAAj1WTWRwK05EpziP4BJn7ka?dl=0
For more information visit: Seratopical.com , Seralabshealth.com and follow us on Instagram at @seratopical , as well as Twitter , and Facebook . Media contact: press@theseralabs.com .
About Sera Labs
Sera Labs® is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting edge technology and superior ingredients such as CBD and clean plant-based products. Sera Labs creates high quality products that use science-backed, proprietary formulations. Its more than 20 products are sold under the brand names Seratopical ™, SeraLabs™, and Gordon’s Herbals™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health & wellness. Sera Labs products are sold in major national drug, grocery chains and mass retailers. The company also sells products under private label to major retailers and multi-level marketers, as well as direct-to-consumer (DTC), via online website orders, including opt-in subscriptions. For more information visit: Seratopical.com , Seralabshealth.com and follow us on Instagram at @seratopical , as well as Twitter , and Facebook . Media contact: press@theseralabs.com .
About Avenir Wellness Solutions Company
Avenir Wellness is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. As a vertically integrated company, AVRW’s 25,000 square foot, FDA-registered, NSF® cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. Avenir has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210609005442/en/
Avenir Wellness [OTC: AVRW] and Canopy Growth to Produce CBD Oral Thin Films
AVRW has an FDA- and DEA- registered, GMP manufacturing facility and is a pioneering developer of CUREform™, a patented drug delivery platform. CUREform™ includes CUREfilm®, one of the most advanced oral thin films on the market today; microCURE™, an innovative emulsion technology utilizing proprietary encapsulation techniques; and CUREpods™ a novel chewable delivery system.
AVRW names Canopy Rivers Chairman John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience to the company, most recently serving as chairman of the Canopy Rivers board of directors and former chairman of Canopy Growth’s board of directors.
AVRW offers combined technologies that provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients. AVRW partners with biotech, pharmaceutical, and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector, with partnerships in the U.S.A, Canada, Israel, and other markets. The AVRW company mission is to improve people’s lives by redefining how medicines are delivered and experienced.
AVRW Products Fall Into Two Categories: Nutraceuticals (dietary supplements) and Pharmaceutical Medicines
Nutraceuticals:
CUREfilm® Sleep is a daily dietary supplement that delivers a unique blend of five active ingredients with the CUREfilm® platform to promote healthy sleep patterns. This product is launched in U.S. markets.
CUREfilm® D is a high-potency dietary supplement that provides 50,000 IU of Vitamin D3 delivered with the CUREfilm® platform.
CUREfilm™ Hemp delivers hemp extracts via the CUREfilm® dosage form. This product is launched in U.S. markets.
CUREfilm® β-Caryophyllene is a dietary supplement that contains 30mg of β-Caryophyllene, a powerful terpene known for its anti-inflammatory and analgesic properties.
Pharmaceuticals:
CUREfilm® Blue contains 50mg of Sildenafil delivered with the CUREfilm® platform.
CUREfilm® Canna delivers synthetic and plant-derived cannabinoids in an oral thin film for pharmaceutical indications.
AVRW Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery
On February 5th AVRW announced that it had signed an exclusive licensing agreement with ReLeaf Europe, one of Europe’s leading pharmaceutical groups specialized in medicinal cannabis products. The agreement grants ReLeaf Europe exclusive access to the AVRW encapsulation technology for certain oral and topical cannabis products in the Netherlands, the world’s first medical cannabis market. ReLeaf Europe products will be the first to use the CUREinside™ quality mark to bolster consumer confidence. Europe is one of the world’s largest medical cannabis markets due to various governments’ approval for medicinal purposes.
ReLeaf Europe is one of the few pharmacy providers of pharmaceutical-grade medicinal cannabis oils in Europe and an ideal partner for the AVRW first step into the European market because of its commitment to establishing clinical evidence and following EU GMP and GDP standards. Through this agreement, AVRW will roll out its powered by CURE strategy that includes exclusive licensing relationships to build global market share.
ReLeaf Europe is tackling the largest market in the world for cannabis by establishing a foothold in Holland — a market estimated to reach $2.6B by 2028 — and by pursuing innovative delivery systems and distribution networks. AVRW will power several ReLeaf Europe products, including one sublingual tincture and two topical creams to be launched in 2020.
Major Earnings Potential in the Emerging Medicinal Cannabis Industry
The Cannabis plant has an estimated 113 different compounds, out of which THC and CBD are the two main constituents. THC is mainly responsible for the psychoactive effects or the
feeling of “high” caused by the use of cannabis. CBD on the other hand, has several powerful anti-inflammatory, analgesic, neuroprotective and anti-anxiety properties, which explains its growing popularity to treat a plethora of medical conditions. Unlike THC, CBD does not have any psychotropic effects and hence is widely preferred.
CBD is now being used to treat a wide array of medical conditions such as cancer, cardiovascular anomalies, arthritis, anxiety, depression and Insomnia. In addition, it has also been proven to possess neuroprotective benefits that can treat diseases such as seizures, Multiple Sclerosis (MS), Alzheimer’s, Parkinson’s and Schizophrenia to name a few. There is a growing preference for CBD over traditional pharmaceutical options as these have minimal side effects and are non-addictive.
The global legal marijuana market is likely to reach over USD 66.3 billion by the end of 2025, as per a report by Grand View Research, Inc, growing at a CAGR of 23.9%. There is a growing acceptance of the curative effects of cannabis, with some countries such as Canada and certain states of U.S legalizing the use of Marijuana for medical and recreational use. Research has time and again shown that cannabinoids (CBD), extracted from the cannabis plant, have varied medical uses with minimal side effects, making it a sought-after alternative to traditional pharmaceutical options.
AVRW has signed a licensing and collaboration agreement with
Vanguard Scientific Systems, Inc.
Vanguard is a premier provider of equipment, systems and performance solutions servicing the botanical extraction industry, including the MIDAS XII, a next-generation GMP compliant supercritical CO2 extraction technology, as well as industrially scaled CO2 facility solutions. The license gives Vanguard the right to practice CURE’s patented cannabis extraction methods, providing customer confidence in choosing Vanguard’s portfolio of extraction manufacturers
The industry is poised to grow to $2.1 billion in 2020, a 700% increase from 2016. Those numbers are not only appealing to the players in the CBD market but also serve as an incredible opportunity the pharmaceutical companies to create novel solutions for disease with large unmet medical needs. AVRW is strategically positioned with multiple high value assets and extremely well-placed marketing partners to optimize the company’s earnings potential in the growing fields of key drug supply and delivery solutions, including the multi-billion-dollar CBD marketplace. For more information on Avenir Wellness (OTCQB: AVRW ) visit: http://www.avenirwellness.com
Company News
02/13/2024 Avenir Wellness Solutions Issues 2024 Marketing Growth Plans to Shareholders for Seratopical Revolution Skin Care Line with Support from Nicole Kidman and
Facial Plastic Surgeon Dr. Michael Persky
09/19/2023 Avenir Wellness Solutions Announces Return of Stock Trading Back to OTCQB Market
08/08/2023 Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity
05/17/2023 Avenir Wellness Solutions Update to Stockholders
04/28/2023 New to The Street Announces the Televised Lineups for Shows 461, 462, and 463; Airings on Three Networks Will Begin on Saturday, April 29, 2023, at 3:30 PM ET
04/26/2023 Avenir Wellness Solutions (OTCQB:CURR) to Present at the Planet MicroCap Showcase - Live Webcast Available
04/25/2023 Avenir Wellness Letter to Stockholders
04/13/2023 New to The Street Announces the Televised Lineups for Shows 452, 457, and 458, Airings on Three Networks Will Begin Tonight, Thursday, April 13, 2023, at 9:30 PM ET
DISCLAIMER:
Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned. Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for information purposes only. No stock exchange has approved or disapproved of the information here.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |